Literature DB >> 18157648

Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial.

Alexander Muacevic1, Berndt Wowra, Axel Siefert, Joerg-Christian Tonn, Hans-Jakob Steiger, Friedrich W Kreth.   

Abstract

BACKGROUND: Is Gamma Knife surgery alone as effective as surgery plus whole brain irradiation (WBRT) for patients with a single, small-sized brain metastasis?
METHODS: Patients aged between 18 and 80 years harboring a single, resectable metastasis < or =3 cm in diameter, a Karnofsky performance score (KPS) > or =70, and a stable systemic disease were randomly assigned to microsurgery plus WBRT or Gamma Knife surgery alone. The primary end point was length of survival, secondary end points were recurrence of tumor in the brain, health related quality of life, and treatment related toxicity.
RESULTS: Due to poor patient accrual, the study was stopped prematurely. The final analysis was based on 33 patients in the surgery and 31 patients in the radiosurgery group. Treatment results did not differ in terms of survival (P = 0.8), neurological death rates (P = 0.3), and freedom from local recurrence (P = 0.06). Patients of the radiosurgery group experienced more often distant recurrences (P = 0.04); after adjustment for the effects of salvage radiosurgery this difference was lost (P = 0.4). Radiosurgery was associated with a shorter hospital stay, less frequent and shorter timed steroid application (P < or = 0.001), and lower frequency of grade 1/2 toxicities (according to the RTOG/EORTC CNS toxicity criteria, P < or = 0.01). Improved scores for role functioning and quality of life were seen 6 weeks after radiosurgery (P < 0.05); this difference was lost 6 months after treatment.
CONCLUSIONS: In patients harboring a single, small-sized metastasis, Gamma Knife surgery alone is less invasive; local tumor control seems to be as high as after surgery plus WBRT. Distant tumor control, however, is significantly less frequently achieved (after radiosurgery alone). The role of radiosurgical salvage therapy (alternatively to WBRT) for distant tumor control deserves further prospective evaluation.

Entities:  

Mesh:

Year:  2007        PMID: 18157648     DOI: 10.1007/s11060-007-9510-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

2.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

3.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

4.  Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients.

Authors:  S R Smalley; E R Laws; J R O'Fallon; E G Shaw; M F Schray
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

5.  Surgery versus radiosurgery in the treatment of brain metastasis.

Authors:  A K Bindal; R K Bindal; K R Hess; A Shiu; S J Hassenbusch; W M Shi; R Sawaya
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

6.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

7.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

Authors:  E M Noordijk; C J Vecht; H Haaxma-Reiche; G W Padberg; J H Voormolen; F H Hoekstra; J T Tans; N Lambooij; J A Metsaars; A R Wattendorff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-07-01       Impact factor: 7.038

8.  Defining the role of radiosurgery in the management of brain metastases.

Authors:  M P Mehta; J M Rozental; A B Levin; T R Mackie; S S Kubsad; M A Gehring; T J Kinsella
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

9.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

10.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.

Authors:  Penny K Sneed; John H Suh; Steven J Goetsch; Seema N Sanghavi; Richard Chappell; John M Buatti; William F Regine; Eduardo Weltman; Vernon J King; John C Breneman; Paul W Sperduto; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-01       Impact factor: 7.038

View more
  81 in total

1.  Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

Authors:  Louis Burt Nabors; Jana Portnow; Mario Ammirati; Henry Brem; Paul Brown; Nicholas Butowski; Marc C Chamberlain; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Jona Hattangadi-Gluth; Deneen Hesser; Matthias Holdhoff; Larry Junck; Ronald Lawson; Jay S Loeffler; Paul L Moots; Maciej M Mrugala; Herbert B Newton; Jeffrey J Raizer; Lawrence Recht; Nicole Shonka; Dennis C Shrieve; Allen K Sills; Lode J Swinnen; David Tran; Nam Tran; Frank D Vrionis; Patrick Yung Wen; Nicole R McMillian; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2014-11       Impact factor: 11.908

Review 2.  Neurosurgical management of metastases in the central nervous system.

Authors:  Elizabeth B Claus
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

3.  Central nervous system cancers.

Authors:  Louis Burt Nabors; Mario Ammirati; Philip J Bierman; Henry Brem; Nicholas Butowski; Marc C Chamberlain; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Deneen Hesser; Matthias Holdhoff; Larry Junck; Ronald Lawson; Jay S Loeffler; Moshe H Maor; Paul L Moots; Tara Morrison; Maciej M Mrugala; Herbert B Newton; Jana Portnow; Jeffrey J Raizer; Lawrence Recht; Dennis C Shrieve; Allen K Sills; David Tran; Nam Tran; Frank D Vrionis; Patrick Y Wen; Nicole McMillian; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-09-01       Impact factor: 11.908

Review 4.  Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer.

Authors:  Thomas M Churilla; Stephanie E Weiss
Journal:  Curr Oncol Rep       Date:  2018-05-07       Impact factor: 5.075

Review 5.  Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases.

Authors:  M G Hart; R Grant; M Walker; H Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 6.  Management of non-small cell lung cancer with oligometastasis.

Authors:  Liza C Villaruz; Gregory J Kubicek; Mark A Socinski
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

7.  Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.

Authors:  Hideyuki Arita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Minako Sumi; Soichiro Shibui
Journal:  J Neurooncol       Date:  2013-10-25       Impact factor: 4.130

Review 8.  Systemic Therapy of Lung Cancer CNS Metastases Using Molecularly Targeted Agents and Immune Checkpoint Inhibitors.

Authors:  Grainne M O'Kane; Natasha B Leighl
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

Review 9.  Treatment of Brain Metastases.

Authors:  Xuling Lin; Lisa M DeAngelis
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

10.  Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis.

Authors:  Berndt Wowra; Alexander Muacevic; Jörg-Christian Tonn
Journal:  J Neurooncol       Date:  2009-02-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.